Regulation of the life cycle of HPVs by differentiation and the DNA damage response.

PubWeight™: 0.87‹?›

🔗 View Article (PMC 3951404)

Published in Future Microbiol on December 01, 2013

Authors

Shiyuan Hong1, Laimonis A Laimins

Author Affiliations

1: Department of Microbiology-Immunology, Northwestern University, Feinberg, School of Medicine, Chicago Avenue, Morton 6-681, Chicago, IL 60611, USA.

Articles cited by this

(truncated to the top 100)

Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. Science (2003) 18.29

The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science (1989) 16.54

The DNA damage response: making it safe to play with knives. Mol Cell (2010) 16.13

Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer (2002) 15.46

Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2007) 13.20

Cell-cycle checkpoints and cancer. Nature (2004) 13.19

Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science (1998) 10.89

ATM activation by DNA double-strand breaks through the Mre11-Rad50-Nbs1 complex. Science (2005) 8.77

Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science (1998) 8.74

ATM- and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks. Nat Cell Biol (2005) 8.27

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet (2006) 7.83

Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J (1989) 7.69

Genomic instability--an evolving hallmark of cancer. Nat Rev Mol Cell Biol (2010) 7.11

Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks. Science (1999) 6.93

H2AX: the histone guardian of the genome. DNA Repair (Amst) (2004) 6.65

The Mre11 complex: at the crossroads of dna repair and checkpoint signalling. Nat Rev Mol Cell Biol (2002) 6.44

TopBP1 activates the ATR-ATRIP complex. Cell (2006) 6.29

Functional uncoupling of MCM helicase and DNA polymerase activities activates the ATR-dependent checkpoint. Genes Dev (2005) 5.53

The DNA damage response and cancer therapy. Nature (2012) 5.25

Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer (2010) 4.99

The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair. Nat Cell Biol (2005) 4.62

The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer. Adv Cancer Res (2010) 4.44

Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One (2008) 4.24

ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage. Genes Dev (2001) 4.06

Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. Lancet Oncol (2011) 3.98

Mechanisms of human papillomavirus-induced oncogenesis. J Virol (2004) 3.95

Phosphorylation of SMC1 is a critical downstream event in the ATM-NBS1-BRCA1 pathway. Genes Dev (2004) 3.76

Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I. Science (1995) 3.43

BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage. Nat Genet (2002) 3.11

The DNA damage-dependent intra-S phase checkpoint is regulated by parallel pathways. Nat Genet (2002) 2.97

Rapid activation of ATR by ionizing radiation requires ATM and Mre11. J Biol Chem (2006) 2.76

A human homologue of the checkpoint kinase Cds1 directly inhibits Cdc25 phosphatase. Curr Biol (1999) 2.73

DNA repair dysregulation from cancer driver to therapeutic target. Nat Rev Cancer (2012) 2.70

The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300. EMBO J (1999) 2.44

The p53-dependent G1 cell cycle checkpoint pathway and ataxia-telangiectasia. Cancer Res (1994) 2.41

Disruption of either the E1 or the E2 regulatory gene of human papillomavirus type 16 increases viral immortalization capacity. Proc Natl Acad Sci U S A (1992) 2.30

ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage. EMBO J (2005) 2.29

Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity. Rev Med Virol (2006) 2.22

Human papillomaviruses activate the ATM DNA damage pathway for viral genome amplification upon differentiation. PLoS Pathog (2009) 2.21

The effects of deregulated DNA damage signalling on cancer chemotherapy response and resistance. Nat Rev Cancer (2012) 2.20

Chromatin remodeling at DNA double-strand breaks. Cell (2013) 2.18

Positive regulation of Wee1 by Chk1 and 14-3-3 proteins. Mol Biol Cell (2001) 2.00

Caffeine abolishes the mammalian G(2)/M DNA damage checkpoint by inhibiting ataxia-telangiectasia-mutated kinase activity. J Biol Chem (2000) 2.00

Common fragile sites are preferential targets for HPV16 integrations in cervical tumors. Oncogene (2003) 2.00

Persistence of human papillomavirus infection: keys to malignant progression. Trends Microbiol (2010) 1.96

Evidence for a switch in the mode of human papillomavirus type 16 DNA replication during the viral life cycle. J Virol (1997) 1.92

Mechanisms of genomic instability in human cancer: insights from studies with human papillomavirus oncoproteins. Int J Cancer (2004) 1.90

Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer. J Clin Microbiol (2006) 1.79

Papillomavirus E6 proteins. Virology (2008) 1.70

DNA damage responses: mechanisms and roles in human disease: 2007 G.H.A. Clowes Memorial Award Lecture. Mol Cancer Res (2008) 1.69

Repeated phosphopeptide motifs in Claspin mediate the regulated binding of Chk1. Nat Cell Biol (2003) 1.68

Interferon-inducible protein, P56, inhibits HPV DNA replication by binding to the viral protein E1. EMBO J (2008) 1.66

Ataxia telangiectasia mutated (ATM) kinase and ATM and Rad3 related kinase mediate phosphorylation of Brca1 at distinct and overlapping sites. In vivo assessment using phospho-specific antibodies. J Biol Chem (2001) 1.60

Dose-dependent regulation of the early promoter of human papillomavirus type 18 by the viral E2 protein. J Virol (1997) 1.59

Papillomavirus E6 and E7 proteins and their cellular targets. Front Biosci (2008) 1.59

Apoptosis associated with deregulated E2F activity is dependent on E2F1 and Atm/Nbs1/Chk2. Mol Cell Biol (2004) 1.57

Integration of human papillomavirus type 16 DNA sequences: a possible early event in the progression of genital tumors. J Virol (1987) 1.54

Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway. Proc Natl Acad Sci U S A (1994) 1.53

The papillomavirus E1 helicase activates a cellular DNA damage response in viral replication foci. J Virol (2011) 1.49

Human papillomaviruses modulate expression of microRNA 203 upon epithelial differentiation to control levels of p63 proteins. J Virol (2010) 1.45

Conserved herpesvirus kinases target the DNA damage response pathway and TIP60 histone acetyltransferase to promote virus replication. Cell Host Microbe (2011) 1.43

Transcriptional regulation of the papillomavirus oncogenes by cellular and viral transcription factors in cervical carcinoma. Virology (2008) 1.41

Human papillomavirus DNA replication. Interactions between the viral E1 protein and two subunits of human dna polymerase alpha/primase. J Biol Chem (1999) 1.41

Regulation of cellular miRNA expression by human papillomaviruses. Biochim Biophys Acta (2011) 1.40

Differential requirements for conserved E2 binding sites in the life cycle of oncogenic human papillomavirus type 31. J Virol (1998) 1.37

Temporal usage of multiple promoters during the life cycle of human papillomavirus type 31b. J Virol (1998) 1.37

Human papillomaviruses recruit cellular DNA repair and homologous recombination factors to viral replication centers. J Virol (2012) 1.37

E1 protein of human papillomavirus is a DNA helicase/ATPase. Nucleic Acids Res (1993) 1.35

Mechanism of genomic instability in cells infected with the high-risk human papillomaviruses. PLoS Pathog (2009) 1.34

Human papillomaviruses activate caspases upon epithelial differentiation to induce viral genome amplification. Proc Natl Acad Sci U S A (2007) 1.33

Nuclear accumulation of the papillomavirus E1 helicase blocks S-phase progression and triggers an ATM-dependent DNA damage response. J Virol (2011) 1.33

Ataxia telangiectasia-mutated damage-signaling kinase- and proteasome-dependent destruction of Mre11-Rad50-Nbs1 subunits in Simian virus 40-infected primate cells. J Virol (2008) 1.32

Variations in the association of papillomavirus E2 proteins with mitotic chromosomes. Proc Natl Acad Sci U S A (2006) 1.32

The chromatin structure of the long control region of human papillomavirus type 16 represses viral oncoprotein expression. J Virol (1999) 1.32

The l2 minor capsid protein of human papillomavirus type 16 interacts with a network of nuclear import receptors. J Virol (2004) 1.30

A member of the activator protein 1 family found in keratinocytes but not in fibroblasts required for transcription from a human papillomavirus type 18 promoter. J Virol (1990) 1.28

Oct-1 activates the epithelial-specific enhancer of human papillomavirus type 16 via a synergistic interaction with NFI at a conserved composite regulatory element. Virology (1995) 1.24

HPV E6 protein interacts physically and functionally with the cellular telomerase complex. Proc Natl Acad Sci U S A (2009) 1.21

HPV31 E7 facilitates replication by activating E2F2 transcription through its interaction with HDACs. EMBO J (2005) 1.21

Nuclear import strategies of high risk HPV16 L1 major capsid protein. J Biol Chem (2002) 1.17

Engagement of the ATR-dependent DNA damage response at the human papillomavirus 18 replication centers during the initial amplification. J Virol (2012) 1.14

Chk1 C-terminal regulatory phosphorylation mediates checkpoint activation by de-repression of Chk1 catalytic activity. Oncogene (2009) 1.14

Viral integration and fragile sites in human papillomavirus-immortalized human keratinocyte cell lines. Genes Chromosomes Cancer (1992) 1.12

Human papillomavirus (HPV) E7 induces prolonged G2 following S phase reentry in differentiated human keratinocytes. J Biol Chem (2011) 1.11

ATM-dependent spontaneous regression of early Eμ-myc-induced murine B-cell leukemia depends on natural killer and T cells. Blood (2013) 1.09

The search for infectious causes of human cancers: where and why (Nobel lecture). Angew Chem Int Ed Engl (2009) 1.08

ATM and ATR activities maintain replication fork integrity during SV40 chromatin replication. PLoS Pathog (2013) 1.02

The human papillomavirus type 8 E2 tethering protein targets the ribosomal DNA loci of host mitotic chromosomes. J Virol (2008) 1.02

Parvovirus B19 infection of human primary erythroid progenitor cells triggers ATR-Chk1 signaling, which promotes B19 virus replication. J Virol (2011) 1.00

Bap31 is a novel target of the human papillomavirus E5 protein. J Virol (2008) 1.00

Runt-related transcription factor 2 (RUNX2) inhibits p53-dependent apoptosis through the collaboration with HDAC6 in response to DNA damage. Cell Death Dis (2013) 0.99

Suppression of STAT-1 expression by human papillomaviruses is necessary for differentiation-dependent genome amplification and plasmid maintenance. J Virol (2011) 0.99

The inhibitory action of P56 on select functions of E1 mediates interferon's effect on human papillomavirus DNA replication. J Virol (2010) 0.98

p63 is necessary for the activation of human papillomavirus late viral functions upon epithelial differentiation. J Virol (2011) 0.96

Human papillomavirus episome stability is reduced by aphidicolin and controlled by DNA damage response pathways. J Virol (2013) 0.96

The JAK-STAT transcriptional regulator, STAT-5, activates the ATM DNA damage pathway to induce HPV 31 genome amplification upon epithelial differentiation. PLoS Pathog (2013) 0.95

Human papillomavirus E6 proteins mediate resistance to interferon-induced growth arrest through inhibition of p53 acetylation. J Virol (2007) 0.95

Yin yang 1 negatively regulates the differentiation-specific E1 promoter of human papillomavirus type 6. J Virol (2000) 0.94

Interplay between DNA tumor viruses and the host DNA damage response. Curr Top Microbiol Immunol (2013) 0.90

CCAAT/enhancer binding protein beta binds to and activates the P670 promoter of human papillomavirus type 16. Virology (2005) 0.89

Articles by these authors

Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer (2010) 4.99

Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol Mol Biol Rev (2004) 3.52

Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity. Rev Med Virol (2006) 2.22

Human papillomaviruses activate the ATM DNA damage pathway for viral genome amplification upon differentiation. PLoS Pathog (2009) 2.21

Persistence of human papillomavirus infection: keys to malignant progression. Trends Microbiol (2010) 1.96

Human papillomavirus type 31 E5 protein supports cell cycle progression and activates late viral functions upon epithelial differentiation. J Virol (2003) 1.62

Human papillomaviruses: targeting differentiating epithelial cells for malignant transformation. Oncogene (2003) 1.59

Amino acid substitutions that specifically impair the transcriptional activity of papillomavirus E2 affect binding to the long isoform of Brd4. Virology (2006) 1.47

Human papillomaviruses modulate expression of microRNA 203 upon epithelial differentiation to control levels of p63 proteins. J Virol (2010) 1.45

The binding of histone deacetylases and the integrity of zinc finger-like motifs of the E7 protein are essential for the life cycle of human papillomavirus type 31. J Virol (2004) 1.43

Human papillomaviruses recruit cellular DNA repair and homologous recombination factors to viral replication centers. J Virol (2012) 1.37

Role of the PDZ domain-binding motif of the oncoprotein E6 in the pathogenesis of human papillomavirus type 31. J Virol (2004) 1.35

Nuclear accumulation of the papillomavirus E1 helicase blocks S-phase progression and triggers an ATM-dependent DNA damage response. J Virol (2011) 1.33

Human papillomaviruses activate caspases upon epithelial differentiation to induce viral genome amplification. Proc Natl Acad Sci U S A (2007) 1.33

Human papillomavirus genotype 31 does not express detectable microRNA levels during latent or productive virus replication. J Virol (2006) 1.27

Human papillomavirus type 31 replication modes during the early phases of the viral life cycle depend on transcriptional and posttranscriptional regulation of E1 and E2 expression. J Virol (2002) 1.23

Human papillomavirus E7 enhances hypoxia-inducible factor 1-mediated transcription by inhibiting binding of histone deacetylases. Cancer Res (2010) 1.23

HPV31 E7 facilitates replication by activating E2F2 transcription through its interaction with HDACs. EMBO J (2005) 1.21

Hypoxia-specific stabilization of HIF-1alpha by human papillomaviruses. Virology (2009) 1.18

Differentiation of HPV-containing cells using organotypic "raft" culture or methylcellulose. Methods Mol Med (2005) 1.17

Human papillomaviruses target the double-stranded RNA protein kinase pathway. J Gen Virol (2006) 1.16

Role of the E1--E4 protein in the differentiation-dependent life cycle of human papillomavirus type 31. J Virol (2005) 1.16

Roles of the E6 and E7 proteins in the life cycle of low-risk human papillomavirus type 11. J Virol (2004) 1.11

Regulation of human papillomavirus type 31 gene expression during the differentiation-dependent life cycle through histone modifications and transcription factor binding. Virology (2008) 1.10

Human papillomaviruses modulate microRNA 145 expression to directly control genome amplification. J Virol (2013) 1.09

Mechanisms regulating expression of the HPV 31 L1 and L2 capsid proteins and pseudovirion entry. Virol J (2007) 1.08

Induction of the human papillomavirus type 31 late promoter requires differentiation but not DNA amplification. J Virol (2005) 1.06

The role of human papillomaviruses in oncogenesis. Recent Results Cancer Res (2014) 1.06

Human papillomavirus E1 helicase interacts with the WD repeat protein p80 to promote maintenance of the viral genome in keratinocytes. J Virol (2007) 1.04

Human papillomavirus type 31 life cycle: methods for study using tissue culture models. Methods Mol Biol (2005) 1.03

Long-term effect of interferon on keratinocytes that maintain human papillomavirus type 31. J Virol (2002) 1.02

The full-length E1E4 protein of human papillomavirus type 18 modulates differentiation-dependent viral DNA amplification and late gene expression. Virology (2007) 1.01

The fanconi anemia pathway limits human papillomavirus replication. J Virol (2012) 1.01

Bap31 is a novel target of the human papillomavirus E5 protein. J Virol (2008) 1.00

Suppression of STAT-1 expression by human papillomaviruses is necessary for differentiation-dependent genome amplification and plasmid maintenance. J Virol (2011) 0.99

Nuclear export of human papillomavirus type 31 E1 is regulated by Cdk2 phosphorylation and required for viral genome maintenance. J Virol (2010) 0.98

p63 is necessary for the activation of human papillomavirus late viral functions upon epithelial differentiation. J Virol (2011) 0.96

A cyclin-binding motif in human papillomavirus type 18 (HPV18) E1^E4 is necessary for association with CDK-cyclin complexes and G2/M cell cycle arrest of keratinocytes, but is not required for differentiation-dependent viral genome amplification or L1 capsid protein expression. Virology (2011) 0.95

Human papillomavirus E6 proteins mediate resistance to interferon-induced growth arrest through inhibition of p53 acetylation. J Virol (2007) 0.95

The JAK-STAT transcriptional regulator, STAT-5, activates the ATM DNA damage pathway to induce HPV 31 genome amplification upon epithelial differentiation. PLoS Pathog (2013) 0.95

An interaction between human papillomavirus 16 E2 and TopBP1 is required for optimum viral DNA replication and episomal genome establishment. J Virol (2012) 0.91

The E7 open reading frame acts in cis and in trans to mediate differentiation-dependent activities in the human papillomavirus type 16 life cycle. J Virol (2011) 0.90

Analysis of the roles of E6 binding to E6TP1 and nuclear localization in the human papillomavirus type 31 life cycle. Virology (2006) 0.84

Viral transformation of epithelial cells. Methods Mol Biol (2013) 0.75